Over the last 10 years, the development of newer pulse sequences and applications in new clinical areas has enabled cardiovascular magnetic resonance to emerge as a powerful tool for the physicians to both diagnose and guide treatments of various cardiac pathologies. The greatest strengths of cardiovascular magnetic resonance include the assessment of ischemia and viability, evaluation of nonischemic cardiomyopathies, including myocarditis, pericardial disease, congenital heart disease, and tissue characterization of cardiac masses.
O ver the last 10 years, the development of newer pulse sequences and applications in new clinical areas has enabled cardiovascular magnetic resonance (CMR) to emerge as a powerful tool for the physicians to both diagnose and guide treatments of various cardiac pathologies. The greatest strengths of CMR include the assessment of ischemia and viability, evaluation of nonischemic cardiomyopathies, including myocarditis, pericardial disease, congenital heart disease, and tissue characterization of cardiac masses. Appropriate indications for CMR have been incorporated into American College of Cardiology (ACC)/American Heart Association (AHA) guidelines over the last decade and are summarized in Table 1 . 1
CORONARY ARTERY DISEASE
One of the most useful clinical applications of CMR is the evaluation of myocardial viability. Areas of fibrosis and scarring after myocardial infarction (MI) have an increased extracellular space as compared with normal myocardium. Based on this principle, areas of previous MI will appear bright on a T 1 -weighted (T 1 -W) sequence performed 10 to 15 minutes after injection of a gadolinium contrast agent ( Fig. 1 ). 2 The superior spatial resolution of CMR allows detection of subendocardial infarction which may be missed by nuclear medicine techniques. 3 The ability to quantify transmurality of infarction has important clinical implications, particularly when patients are being referred for high-risk percutaneous coronary intervention or coronary artery bypass grafting (CABG). It has been demonstrated that contractility after revascularization with percutaneous coronary intervention or CABG improves in 78% of dysfunctional segments that have no late gadolinium enhancement (LGE), and 60% in those with scar up to 25% of left ventricular (LV) wall thickness. 4 When analyzed by wall segments, anterior wall viability seems to contribute the most to improvement in LV function post-CABG. 5 It is worth noting that 65% to 70% of segments with subendocardial infarct that demonstrate severe hypokinesis, dyskinesis, or akinesis will have an improvement in contractility after revascularization, stressing the importance of viability testing in patients with preoperative LV dysfunction to distinguish hibernating myocardium from regions of transmural scar that are not likely to improve with revascularization. 4, 6 The clinical dilemma of what to recommend for patients who have numerous segments with scar comprising 25% to 50% of LV wall thickness remains, as these segments have an intermediate probability of functional recovery. 4, 6 Using a 16-segment model and a transmural viability cutoff of 50%, patients with 10 or more normal and viable segments had an improvement in global LV ejection fraction (LVEF) Ն3% after CABG (positive predictive value 87%, negative predictive value 89%). 7 Incorporating low-dose dobutamine testing (10 g/kg for 10 minutes) into the CMR protocol may also be useful in this subset of patients. Those dysfunctional segments with up to 50% transmural infarct that demonstrate an improvement in contractility to normal with dobutamine have a significantly greater chance of functional recovery at 4 to 6 months post-CABG when compared with patients without as robust a response. 8 Another study demonstrated that response to dobutamine was superior to transmurality of scar in discriminating those who would have an improvement in function in segments with 1% to 74% transmural scar. 9 Complications of recent MI, such as ventricular septal defect and pseudoaneurysm formation, can be evaluated by CMR (Fig. 2 ). In addition, CMR in the early post-MI period can provide prognostic information. Acute infarct size by LGE and the presence of microvascular obstruction, areas of low signal on late enhanced images, (Fig. 2 ) are more predictive than LVEF or patency of infarct-related artery post-MI in predicting long-term prognosis and adverse LV remodeling. 10 In addition, the presence of microvascular obstruction is a significant predictor of a major adverse cardiac event post MI, whereas there is only a trend toward an increased major adverse cardiac event with larger infarct size. 11 Myocardial salvage index has been shown to be an independent predictor of a major adverse cardiac event in reperfused patients with acute MI. 12 T 2 -weighted (T 2 -W) imaging of myocardial edema defines the area at risk as validated in both animal 13 and clinical models. 14 The salvage index is calculated as the (area at risk Ϫ final infarct size)/area at risk. The area at risk is obtained by identifying areas of myocardial edema (those regions Ͼ2 standard deviations in intensity when compared to normal myocardium), with all values represented as a percentage of total LV mass. A major need in the field is standardization of T 2 -W sequences across CMR centers to enable the myocardial salvage index to become a quantitative tool for future clinical trials involving new reperfusion and infarct size reduction strategies. 12, 15 An advantage of CMR stress testing over other modalities is the ability to assess ischemia and function, and diagnose small, otherwise unrecognized infarcts. Dobutamine stress CMR has a greater sensitivity and specificity than dobutamine stress echocardiography for detecting significant coronary artery disease (CAD; 74% and 70% vs. 86% and 86%), 16 and can be a particularly useful modality for stress testing in obese patients where images from a dobutamine stress echo may be of poor quality and nondiagnostic. A multicenter trial comparing adenosine stress CMR to single-photon emission computed tomography demonstrated that CMR is equivalent, and may be superior to single-photon emission computed tomography for the diagnoses of CAD. 17 The addition of LGE imaging to CMR stress perfusion ( Fig. 3 ) increases specificity and accuracy of diagnosing CAD. 18 When combining LGE and stress perfusion, the absence of LGE or a reversible perfusion defect is associated with a 98.1% negative annual event rate for death or MI, and the presence of LGE alone in patients without a history of MI is associated with an 11-fold increase in hazard ratio for death or MI. 19 In patients with known or suspected CAD, the 3-year event-free survival for patients who have a normal adenosine stress perfusion CMR and dobutamine stress CMR is 99.2%. 20 In a larger cohort of over 1400 patients, dobutamine stress CMR alone demonstrating the absence of inducible wall motion abnormality in patients with low or intermediate risk of CAD was associated with a 99.5% event-free survival. 21 Among patients with an LVEF 40% to 55%, an increase in dobutamine CMR wall motion score index was a predictor of MI and cardiac death. 22 Adenosine stress perfusion CMR has also been shown to be safe early after an acute MI, and is more sensitive and specific compared with exercise treadmill testing in predicting Ͼ70% coronary artery stenoses. 23 The major limitation of CMR stress testing has been the inability to feasibly combine exercise tolerance testing with CMR because of the challenge of obtaining poststress images in a similar position to rest images within a short time frame after exercise. However, a pilot study incorporating exercise tolerance testing and CMR with the use of an inflatable cushion mold to "recall" the patient's position in the MRI scanner minimizes the delay of poststress imaging to under a minute, and may make exercise stress CMR a clinically viable test in the future. 24 Adenosine CMR is a cost-effective method for evaluating patients presenting to the emergency department for evaluation of chest pain without evidence of acute MI. 25 A negative perfusion CMR study in this population has negative predictive values of 100% for a diagnosis of CAD or adverse cardiovascular outcome at 1-year follow-up. 26 There is also an emerging role for CMR in the evaluation of patients presenting with elevated troponin and either a low likelihood of acute coronary syndrome or angiographically normal or nonobstructive CAD. Although the possible etiologies for troponin elevation are broad, the most likely diagnoses in patients with nonobstructed coronary arteries remain acute MI because of spontaneous reperfusion of thrombus, 27 myocarditis, and cardiomyopathy, especially Takotsubo or stress cardiomyopathy. 28 The latter diagnosis may be made by CMR with T 2 -W images positive for edema and the absence of LGE.
A pilot study in patients with elevated troponin and low clinical likelihood of acute coronary syndrome which used a stepwise CMR algorithm used to rule out aortic dissection, acute MI, pulmonary embolus, or myopericarditis, was able to yield a diagnosis in 27 of 29 patients. 29 More importantly, the average scan time was 35 Ϯ 8 minutes, which makes this feasible as an initial test to further risk stratify such patients. Although the cost-effectiveness of such an approach needs to be investigated in larger study populations, the ability of CMR to correctly identify patients with acute coronary syndrome who should undergo angiography, and prevent potentially unnecessary angiography in patients with a noncoronary etiology of troponin elevation, is promising.
CARDIOMYOPATHIES
Although a small group of patients with dilated cardiomyopathy can have subendocardial and transmural LGE similar to patients with CAD, it is more common to have either no LGE or LGE in a midmyocardial distribution. 30 This can be a useful tool to distinguish ischemic from nonischemic etiologies of cardiomyopathy, as those with ischemic cardiomyopathy will usually have LGE in a coronary distribution that is either subendocardial or transmural, but not midmyocardial. 30 In several prospective cohorts of patients with dilated cardiomyopathy, LGE predicted adverse cardiovascular outcomes and episodes of sudden cardiac death and ventricular tachycardia, independent of adverse LV remodeling. 31, 32 Although an echocardiogram is frequently the initial screening test for hypertrophic cardiomyopathy (HCM), CMR can be useful in cases of suspected apical variant HCM, as the apex can be difficult to adequately visualize by echo because of foreshortening or suboptimal windows. 33 CMR can also identify cases of extreme wall thickness (Ͼ3 cm) where echo had underestimated the degree of hypertrophy, particularly in the anterolateral wall. 34, 35 Because LV wall thickness Ͼ3 cm is an established risk factor for sudden cardiac death, 36 obtaining maximal wall thickness in HCM patients is important when considering placement of implantable cardio- verter defibrillators for primary prophylaxis. Typically, the pattern of LGE in HCM is that of focal or patchy enhancement in the midmyocardium, most common in those segments with the greatest LV wall thickness 35 and at the right ventricular (RV) insertion sites. It is, however, important to distinguish LV hypertrophy because of HCM from other disease states associated with LV hypertrophy, such as Anderson-Fabry disease, because such a diagnosis may lead to treatment with ␣-galactosidase enzyme replacement therapy. The LGE pattern of Anderson-Fabry disease is focal, typically endocardial-sparing with a high predelection for the basal inferolateral wall. 37 Several studies have demonstrated an association between LGE and ventricular arrhythmias on Holter monitor, 38 appropriate implantable cardioverter defibrillator discharge, 39 and cardiac mortality in an otherwise low-risk or asymptomatic HCM population. 40 However, larger registries of HCM patients are needed to determine whether screening for specific patterns of LGE or quantifying LGE may improve the current guidelines for assessing risk of sudden cardiac death. 41 Although CMR is able to identify areas of fat and fibrosis, the ability to reliably detect these features within the RV is challenging even in experienced CMR centers, 42 likely because of the presence of epicardial fat and the thin-walled RV. The finding of fat, however, is a nonspecific finding and thus, there are no major or minor Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) Task Force criteria based on CMR findings of fatty infiltration or LGE of the RV. The most recent proposed modification of the Task Force Criteria incorporates one major and one minor criterion by CMR that may be met based on abnormal regional RV function with either abnormal global RV function or size ( Table 2 ). 43 Routine calculation of the RVEF should be part of the assessment for ARVC, as a qualitative assessment of RV function may incorrectly classify patients with RV dysfunction as normal. 44 CMR can be a useful tool in establishing a diagnosis of cardiac amyloidosis. Characteristic LGE patterns have been present in 69% to 97% of biopsy-proven cases. 45, 46 In one series, 100% of histologically confirmed cases of senile amyloid were detected by CMR 45 One of the hallmark findings of amyloidosis is the inability to find an inversion time to null the myocardium while preparing to obtain LGE images. This is because of diffuse infiltration of the myocardium with amyloid 
Indications for CMR

Assessment of ventricular function and myocardial viability in
Major Minor
Regional RV akinesia or dyskinesia or dyssynchronous RV contraction and 1 of the following Regional RV akinesia or dyskinesia or dyssynchronous RV contraction and 1 of the following Ratio of RV end-diastolic volume to BSA Ն110 mL/m 2 (male) or Ն100 mL/m 2 (female)
Ratio of RV end-diastolic volume to BSA Ն100 to Ͻ110 mL/m 2 (male) or Ն90 to Ͻ100 mL/m 2 (female) RV ejection fraction Յ40%.
RV ejection fraction Ͼ40% to Յ45%
A diagnosis of ARVC requires 2 major, 1 major plus 2 minor criteria, or 4 minor criteria from different categories. RV indicates right ventricular; BSA, body surface area.
protein, resulting in delayed washout of gadolinium in this increased intracellular space. Difficulty nulling the myocardium can also occur in other conditions associated with diffuse LGE, such as systemic sclerosis 47, 48 and after orthotopic heart transplant. 49 The most common patterns of LGE in amyloidosis are either global subendocardial or global transmural; however, patchy LGE may also be seen. 45 Other features of amyloidosis, such as biventricular dysfunction, increased wall thickness, biatrial enlargement, and pericardial effusion, are also readily detected by CMR. Among patients with systemic amyloidosis, an abnormal CMR (defined as inability to null myocardium with an inversion time Ͼ300 milliseconds) was associated with significantly decreased survival at 2 years as compared with those with a negative CMR (14% vs. 77% survival). 50 However, congestive heart failure was the only independent predictor of survival by multivariate analysis. Gadolinium kinetics, rather than the presence of LGE, predicts prognosis, as a difference between T1 in the subepicardium and subendocardium of Ͻ23 milliseconds measured 2 minutes after gadolinium administration is associated with decreased survival. 51 MR imaging is a useful way to noninvasively assess iron content of organs in disease states where iron deposition can occur and result in cardiomyopathy, such as hemochromatosis and thalassemia. Attenuation of signal intensity in the liver relative to skeletal muscle on spin-echo and gradient-recalled-echo MR imaging correlates with increased hepatic iron. 52, 53 Newer gradient-recalled-echo sequences have been developed that are able to measure myocardial T2*, which reflects differences in relaxation in tissues with iron deposition because of local inhomogeneity of magnetic fields. 54, 55 A T2* value of Ͻ20 milliseconds is associated with reduced LV function. 54 CMR can also be used to serially follow patients with thalassemia major to assess effectiveness of chelation therapies in decreasing myocardial iron content and improving LV function. 56, 57 The prevalence of cardiac sarcoidosis is 27% based on autopsy findings. 58 The yield of endomyocardial biopsy for the diagnosis of cardiac sarcoidosis is low, likely because of the focal nature of involvement. 59 Cardiac involvement of sarcoidosis by CMR may demonstrate areas of thinning, segmental wall motion abnormalities, focal areas of myocardial edema, and nodular midmyocardial or subepicardial LGE (Fig. 4) .
LGE is most commonly seen in basal and lateral segments. 60 When compared with established Japanese Ministry Criteria, the presence of LGE identifies twice as many biopsy-proven cases of cardiac sarcoid. 61 As the characteristics of cardiac lesions seem to mirror systemic disease activity, CMR may be a noninvasive method for following the success of corticosteroid therapy. 62 In a cohort of patients with biopsy-proven extracardiac sarcoidosis, those who had LGE had a higher rate of cardiac death as compared with those who did not. 61 The superior spatial resolution of CMR as compared with echocardiography makes it an excellent technique for diagnosing cardiomyopathies that depend on accurate measurements of LV wall thickness and identification of abnormal trabeculation, as in LV noncompaction. Thought to arise from cessation of the normal process of myocardial compaction early in utero, the characteristic abnormal finding is a layer of abnormal, sponge-like trabeculation on top of a thin compacted layer of myocardium. 63 The advantages of CMR over echocardiography in the evaluation of LV noncompaction is the ability to analyze all myocardial segments by CMR, and the potential for underestimating the noncompacted/compacted myocardium at end-systole by echo. 64 By CMR, noncompaction is most prominent in the apical and lateral walls. 65 Accepted echocardiographic criteria for LV noncompaction include findings of a large network of noncompacted myocardium with confirmation of crypt-like recesses by color Doppler, and an endsystolic ratio of noncompacted to compacted myocardium of Ͼ2. 66 Specific CMR criteria have been proposed, which include a noncompacted/compacted myocardium of Ͼ2.3 in diastole, 65 and trabeculated LV mass Ͼ20% of total LV mass. 67 
MYOCARDITIS
In cases of possible myocarditis, CMR is an excellent test to obtain functional information as well as provide tissue characterization to aid in diagnosis. Areas of inflammation and edema will have either a focal or diffuse increase in T 2 signal relative to areas of normal myocardium or skeletal muscle. Early after gadolinium administration, global enhancement of the myocardium may be visualized on steadystate free precession or fast-spin-echo T 1 -W images. The negative predictive value for acute myocarditis has been reported to be 100% for patients without areas of edema seen on T 2 -W images or earlypostcontrast global enhancement. 68 The Lake Louise Consensus Criteria for diagnosing myocarditis by CMR requires that at least 2 of the following 3 conditions should be met: (1) regional or global increase in signal intensity on T 2 -W images, (2) increased global myocardial early gadolinium enhancement ratio between myocardium and skeletal muscle in gadolinium-enhanced T 1 -W images, (3) at least one focal LGE lesion with nonischemic regional distribution on LGE images. 69 Repeat imaging is recommended in 1 to 2 weeks after presentation if there is a high clinical suspicion but a negative or inconclusive initial CMR study. 69 LGE is most commonly seen in the posterolateral wall, and may be either subepicardial or midmyocardial (Fig. 5 ). 70 In the convalescent phase, the majority of patients will have areas of persistent LGE which are smaller than in the acute phase, because of healing and retraction of scar. 71
PERICARDIAL DISEASE
CMR can offer both anatomic and functional information to aid in the diagnosis of pericardial diseases. The pericardium can be clearly visualized by CMR on black-blood and steady-state free precession images, and is generally considered to be thickened if it measures Ն4 mm. Findings on CMR suggestive of constrictive pericarditis include a dilated inferior vena cava, atrial enlargement, and pleural or pericardial effusions. Diastolic septal flattening by CMR has a sensitivity of 81% and specificity of 100% for constrictive pericarditis among patients with suspected disease. 72 Obtaining a real-time cine image in a short-axis, midventricular plane is optimal to assess for ventricular interdependence, as diaphragmatic excursion during the respiratory cycle is clearly visualized in this LGE is also present in the RV free wall.
Cardiology in Review • Volume 19, Number 5, September/October 2011 Cardiovascular Magnetic Resonance view. In addition to cine images (Fig. 6 ), myocardial tagging can identify areas of focal adhesion of the pericardium to myocardium. 73 Areas of LGE in constrictive pericarditis correlate histologically with pericardial fibrosis. 74 CMR can also be helpful in differentiating between constrictive pericarditis and restrictive cardiomyopathy, with a relative atrial volume ratio (left atrial volume/right atrial volume) cutoff of Ͼ1.32 yielding a sensitivity and specificity of 83% and 86%, respectively, for the diagnosis of constrictive pericarditis. 75 In the setting of acute pericarditis, the pericardium can appear bright on T 2 -W images, consistent with inflammation, and corre-sponding diffuse LGE of the pericardium can be seen. 76 Although clinical assessment and echocardiography remain the mainstays of diagnosing pericardial tamponade, CMR can demonstrate findings of right atrial or RV collapse, and the presence of a loculated effusion. CMR can also be useful in characterizing the size and location of pericardial cysts and diagnosing congenital absence of the pericardium. 77
INTRACARDIAC MASSES
CMR is able to characterize cardiac masses based on tissue composition and appearance on specific sequences (Table 3) . Generally, tumors will demonstrate perfusion on first-pass perfusion images. Comparing precontrast and early postcontrast T 1 intensity of a mass is also a helpful tool, as most tumors will demonstrate an increase in signal intensity relative to precontrast T 1 images. Metastases to the heart can also be detected, appearing in the form of pericardial thickening or nodularity, pericardial effusion, or direct involvement of the myocardium. Although breast cancer, lung cancer, and lymphoma are the most prevalent malignances with cardiac involvement, melanoma has the greatest affinity for cardiac metastasis. 78, 79 For suspected cases of pericardial involvement, myocardial tagging is often a useful sequence for localizing areas of adherence to the myocardium.
When compared with noncontrast and contrast echocardiography, CMR is more sensitive in detecting LV thrombi, particularly those that are small or mural. 80 -82 It is important to realize that thrombus will have different CMR signal characteristics depending on the pulse sequence. In a black blood image, thrombus may appear slightly more intense or isointense relative to the myocardium, whereas on cine-CMR it will appear as a hypointense filling defect relative to the blood pool. Repeating cine images that are suspicious for thrombus after contrast administration may improve resolution between suspected filling defects in the LV cavity and the blood pool. Typically, thrombus on LGE imaging appears black, characteristic of avascular tissue (Fig. 1) . However, the appearance of thrombus on LGE images may vary depending on age of thrombus, as organized thrombus occasionally takes up contrast, 83, 84 which can produce a heterogenous pattern on late enhanced images. Using a long T 1 (600 milliseconds) to prepare T 1 -W postcontrast images can also better delineate thrombus from myocardium. Thrombus will appear dark, as this longer T 1 surpasses the inversion time needed to null normal myocardium, which will appear gray. 80 LGE CMR imaging has been shown to be superior to cine MR and dark blood haste imaging 81, 85 in the detection of LV thrombus. In one study of patients with LV systolic dysfunction undergoing CMR primarily for the assessment of viability or etiology of cardiomyopathy, the overall prevalence of LV thrombus detected by LGE was 7%. 85 Thrombus was more likely to be present in patients with ischemic cardiomyopathy, more severe LV dysfunction, and increased scar burden detected by LGE.
VALVULAR HEART DISEASE
Although echocardiography still remains the accepted noninvasive modality for anatomic and functional evaluation of valvular heart disease, CMR can also be a useful method to evaluate the severity of valvular disease and the hemodynamic effects of the lesion on chamber sizes and ventricular function ( Fig. 7) . Throughplane velocity-encoded imaging can provide information regarding forward and regurgitant flow in addition to peak velocity across a valve plane. In-plane velocity-encoded imaging can help localize the site of maximal stenosis in more challenging cases such as discrete subvalvular aortic stenosis. Criteria for grading aortic and mitral insufficiency by CMR have been proposed by correlating echocardiographic parameters with CMR regurgitant volume as follows: mild, Ͻ15%; moderate, 16% to 25%; moderate-to-severe, 26% to 48%; and severe, Ͼ48%. 86 Assessment of aortic and mitral insufficiency by CMR can be particularly helpful in cases where the regurgitant jet is eccentric, and severity underestimated by echocardiography. Planimetry of mitral valve area by CMR correlates well with calculations by catheterization (Gorlin formula) and echocardiography (pressure-half time method); however, CMR tends to overestimate the valve area by 5% to 8%. 87 Grading severity of aortic stenosis by CMR can be performed by continuity equation similar to echocardiography, and determining peak and mean gradient. 88 Because of artifact and resultant errors in velocity encoding, CMR is not optimal for assessing the hemodynamics of mechanical valve prostheses (Fig. 8 ).
ELECTROPHYSIOLOGY APPLICATIONS
CMR plays an integral role in guiding ablation therapies. MR angiography of the left atrium is helpful to operators when planning where to deliver ablation lesions, as variations in pulmonary vein anatomy are common, with only 40% of patients having a typical anatomy of 2 separate right-sided and left-sided veins. 89 Common variants include a common ostium for the left-sided veins, and the presence of a right middle pulmonary vein. Electroanatomic mapping merged with 3D MR angiography data reduces fluoroscopy time for the procedure 90 and may also improve outcomes. 91 Although measurement of left atrial volume by CMR is reproducible and is a predictor of successful atrial fibrillation ablation, 92 quantification of left atrial scarring by LGE preablation has become a useful tool in helping to select optimal patients for ablation therapy, as those with more left atrial fibrosis have a greater chance of recurrence. 93 More recently, the degree of left atrial fibrosis has been shown to be an independent predictor of stroke, and might be used in the future along with traditional clinical predictors (CHAD score) to provide an incremental risk stratification for stroke in patients with atrial fibrillation. 94 Given the observation that up to one-third of patients with severe LV dysfunction do not have symptomatic improvement with cardiac resynchronization therapy, 95 additional information provided by CMR can help to select candidates likely to derive the most benefit. A combination of LGE MR with assessment of dyssynchrony by myocardial tagging has a positive predictive value and negative predictive values of 93% and 100%, respectively, for predicting those who will have an improvement in functional class after cardiac resynchronization therapy implantation. 96 
CONGENITAL HEART DISEASE
The anatomic imaging of congenital lesions is inherently complex, and can pose a challenge in many patients for whom echocardiography yields suboptimal images. CMR can be viewed as complementary to echocardiography in patients with complex congenital heart disease and is superior at imaging extracardiac anatomy and the great vessels. There are several adult congenital populations in whom CMR can yield quantitative information to guide clinical decision making. The timing of pulmonic valve replacement for patients with repaired Tetralogy of Fallot who have severe pulmonic insufficiency is controversial. However, prospective studies propose a cutoff of RV volume indexed to a body surface area between 150 and 160 mL/m 297,98 for pulmonic valve replacement, as those with RV volumes above these values are less likely to normalize RV volumes postoperative ( Fig. 9 ). With the possibility of approved percutaneous options for pulmonic valve replacement on the horizon, 99 CMR can be used to measure RV outflow tract dimensions for sizing of prostheses. CMR combined with a clinical assessment in patients without a previous screening test has been proposed as a cost-effective method for detecting late complications after repair of coarctation of the aorta. 100 In one retrospective analysis of patients less than 2 years of age when coarctation repair was performed and were undergoing CMR for routine surveillance and clinical indications, recoarctation of the aorta was seen in 68% of patients. 101 Furthermore, patients with previous coarctation repair who have a bicuspid aortic valve, have significantly larger measurements of the aortic root when compared with patients with tricuspid aortic valves. 101, 102 CMR is a comprehensive test for this select group of patients, as it can demonstrate complications at the site of coarctation repair, assess aortic valve morphology ( Fig. 10) and function, and screen for the aortopathy that is associated with bicuspid aortic valves. 1
CONCLUSIONS
CMR is a versatile tool to guide the diagnosis and treatment of a wide range of cardiovascular diseases. The cornerstone of current CMR practice remains the assessment of viability, ventricular function, and myocardial tissue characterization. As the importance of information gleaned from CMR is increasingly recognized, CMR will become increasingly invaluable to patient care. 
